gas pains on glp 1 Throwing Up a GLP-1: Causes, Management and When to Seek Help – Bolt Pharmacy Digestive Health and GLP-1 Medications:

By customizing the approach, we optimize the treatment process while ensuring safe and effective long-term weight management journeys

The shaded range on the chart represents the approximate 25th to 75th percentile of outcomes, giving you a sense of the typical spread rather than just the average

The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication

Not every patient needs GLP-1 injections, and not every patient is a candidate

The answer is yes but slowly